Approval · Notice of Compliance 10645 · 2009
SABRIL: Notice of Compliance 10645
Issued October 6, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10645
- Date
- October 6, 2009
- Company
- Lundbeck Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiepileptic
Products in this notice
Medicinal ingredients
- VIGABATRIN 500 MG per PCK
- VIGABATRIN 500 MG per TAB